80 related articles for article (PubMed ID: 25816420)
1. Corrigendum.
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):146. PubMed ID: 25816420
[TBL] [Abstract][Full Text] [Related]
2. Suppression of CD4+ T lymphocyte activation in vitro and experimental encephalomyelitis in vivo by the phosphatidyl inositol 3-kinase inhibitor PIK-75.
Acosta YY; Montes-Casado M; Aragoneses-Fenoll L; Dianzani U; Portoles P; Rojo JM
Int J Immunopathol Pharmacol; 2014; 27(1):53-67. PubMed ID: 24674679
[TBL] [Abstract][Full Text] [Related]
3. [Corrigendum] Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1.
Abdelbaset-Ismail A; Pedziwiatr D; Schneider G; Niklinski J; Charkiewicz R; Moniuszko M; Kucia M; Ratajczak MZ
Int J Oncol; 2019 Mar; 54(3):1134. PubMed ID: 30628648
[TBL] [Abstract][Full Text] [Related]
4. Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
J Neurochem; 2017 May; 141(3):473-474. PubMed ID: 28417467
[TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] Upregulated LMO1 in prostate cancer acts as a novel coactivator of the androgen receptor.
Gu H; Liu T; Cai X; Tong Y; Li Y; Wang C; Li F
Int J Oncol; 2016 Mar; 48(3):1306. PubMed ID: 26783042
[TBL] [Abstract][Full Text] [Related]
6. Design of peptidase-resistant peptide inhibitors of myosin light chain kinase.
Khapchaev AY; Kazakova OA; Samsonov MV; Sidorova MV; Bushuev VN; Vilitkevich EL; Az'muko AA; Molokoedov AS; Bespalova ZD; Shirinsky VP
J Pept Sci; 2016 Nov; 22(11-12):673-681. PubMed ID: 27699916
[TBL] [Abstract][Full Text] [Related]
7. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
[TBL] [Abstract][Full Text] [Related]
8. Regulatory CD4(-)CD8(-) double negative T cells.
Kim EY; Juvet SC; Zhang L
Methods Mol Biol; 2011; 677():85-98. PubMed ID: 20941604
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum to Essential components of methods papers.
Leist M; Hengstler JG
ALTEX; 2019; 36(3):506. PubMed ID: 31329256
[TBL] [Abstract][Full Text] [Related]
10. [Corrigendum] Sequence analysis of the Pre‑S gene in chronic asymptomatic HBV carriers with low‑level HBsAg.
Wang T; Dai Y; Zhang M; Cui D; Xu X; Sun C; Cheng J
Int J Mol Med; 2019 Mar; 43(3):1553. PubMed ID: 30628665
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to Normalization of data for viability and relative cell function curves.
Krebs A; Nyffeler J; Rahnenführer J; Leist M
ALTEX; 2019; 36(3):505. PubMed ID: 31329254
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum.
J Health Psychol; 2018 May; 23(6):889. PubMed ID: 29558823
[TBL] [Abstract][Full Text] [Related]
13. [Corrigendum] Nonsense-mediated mRNA decay factor Upf2 exists in both the nucleoplasm and the cytoplasm.
Tatsuno T; Nakamura Y; Ma S; Tomosugi N; Ishigaki Y
Mol Med Rep; 2017 Dec; 16(6):8573. PubMed ID: 28944923
[TBL] [Abstract][Full Text] [Related]
14. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis.
Chu CQ; Wittmer S; Dalton DK
J Exp Med; 2000 Jul; 192(1):123-8. PubMed ID: 10880533
[TBL] [Abstract][Full Text] [Related]
15. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
[TBL] [Abstract][Full Text] [Related]
16. A lymphocyte differentiation and activation antigen, CZ-1, that distinguishes between CD8+ and unstimulated CD4+ T lymphocytes.
Vargas-Cortes M; O'Donnell CL; Appel MC; Maciaszek JW; Yurkunas KS; Welsh RM
Eur J Immunol; 1992 Apr; 22(4):1043-7. PubMed ID: 1348027
[TBL] [Abstract][Full Text] [Related]
17. [Novel peptide inhibitors of the myosin light chain kinase suppress hyperpermeability of vascular endothelium].
Marchenko AV; Stepanova EO; Sekridova AV; Sidorova MV; Bushuev VN; Bespalova ZhD; Shirinskiĭ VP
Biofizika; 2010; 55(6):1008-13. PubMed ID: 21268344
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum.
J Vet Diagn Invest; 2015 May; 27(3):401. PubMed ID: 25901002
[TBL] [Abstract][Full Text] [Related]
19. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
Front Immunol; 2018; 9():15. PubMed ID: 29403497
[TBL] [Abstract][Full Text] [Related]
20. IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Kavrochorianou N; Evangelidou M; Markogiannaki M; Tovey M; Thyphronitis G; Haralambous S
J Leukoc Biol; 2016 Jan; 99(1):175-88. PubMed ID: 26232452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
